US Patent Issued to CureVac on July 29 for "Nucleic acids encoding CRISPR-associated proteins and uses thereof" (German Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,699, issued on July 29, was assigned to CureVac SE (Tubingen, Germany).

"Nucleic acids encoding CRISPR-associated proteins and uses thereof" was invented by Frederic Chevessier-Tunnesen (Tubingen, Germany), Marion Poenisch (Tubingen, Germany) and Thomas Schlake (Tubingen, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of biomedicine, and in particular to the field of therapeutic nucleic acids. The present invention provides artificial nucleic acids, in particular RNAs, encoding CRISPR-associated proteins. A (pharmaceutical) composition and kit-of-parts comprising the same are also provided. Furtherm...